Published in Ann Intern Med on July 15, 1998
Neurological manifestations of Behçet's disease in Japan: a study of 54 patients. J Neurol (2010) 1.11
Thrombophilia Due to Factor V and Factor II Mutations and Formation of a Dural Arteriovenous Fistula: Case Report and Review of a Rare Entity. Skull Base (2008) 0.98
Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factors for venous thromboembolism in women. Curr Control Trials Cardiovasc Med (2001) 0.93
Risk factors of thrombosis in abdominal veins. World J Gastroenterol (2008) 0.82
Phenotypic Heterogeneity in Patients with Homozygous Prothrombin 20210AA Genotype. A paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn (2006) 0.80
The relationship between the prothrombin upstream sequence element and the G20210A polymorphism: the influence of a competitive environment for mRNA 3'-end formation. Nucleic Acids Res (2005) 0.80
Concomitant homozygosity for the prothrombin gene variant with mild deficiency of antithrombin III in a patient with multiple hepatic infarctions: a case report. J Med Case Rep (2010) 0.79
Benign intracranial hypertension associated to blood coagulation derangements. Thromb J (2006) 0.78
Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings. J Med Genet (2007) 0.78
Acute Renal Infarction With Heritable Coagulopathy and Patent Foramen Ovale. Radiol Case Rep (2016) 0.78
Functional single nucleotide polymorphism-based association studies. Hum Genomics (2006) 0.75
The impact of molecular medicine upon early cardiovascular drug development. Br J Clin Pharmacol (2000) 0.75
Upper extremity deep vein thrombosis presenting to a chiropractic clinic: a description of 2 cases. J Chiropr Med (2012) 0.75
Acute Renal Infarction With Heritable Coagulopathy and Patent Foramen Ovale. Radiol Case Rep (2015) 0.75
Bilateral cavo-ilio-femoral thrombosis in an adolescent with transient anti-phospholipid antibodies and factor V heterozygous mutation: a case report. Cases J (2009) 0.75
C20209T prothrombin gene mutation associated deep venous thrombosis in a hemodialysis patient. Clin Nephrol Case Stud (2014) 0.75
Acute Unilateral Renal Infarction in the Setting of an Inherited Thrombophilia and Atrial Septal Defect. Case Rep Hematol (2017) 0.75
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost (2005) 3.47
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol (2001) 3.06
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol (2000) 2.13
Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab (1996) 1.68
Genetic modulation of oral anticoagulation with warfarin. Thromb Haemost (2000) 1.67
Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol (2005) 1.64
Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia (2005) 1.63
Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest (2000) 1.60
High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis. Am J Gastroenterol (2001) 1.60
Mortality and causes of death in Italian persons with haemophilia, 1990-2007. Haemophilia (2010) 1.59
Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol (1998) 1.49
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol (1996) 1.49
Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Blood (1983) 1.44
Polymorphism of the angiotensin-converting enzyme gene in end-stage renal failure patients. Nephron (2000) 1.43
More on: factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first-intended pregnancy: the matched case-control 'NOHA first' study. J Thromb Haemost (2006) 1.41
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost (2006) 1.37
Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology (2000) 1.27
Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol (1999) 1.25
A randomized study comparing retroperitoneal drainage with no drainage after lymphadenectomy in gynecologic malignancies. Gynecol Oncol (1997) 1.23
Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction. Leukemia (2013) 1.21
Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med (1985) 1.15
The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost (1998) 1.13
Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer (2000) 1.13
Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost (1997) 1.11
Recommendations for prophylaxis of pregnancy-related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines. J Thromb Haemost (2013) 1.10
Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism. Thromb Haemost (1999) 1.09
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arterioscler Thromb Vasc Biol (2002) 1.08
Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry (1993) 1.08
The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. Br J Rheumatol (1997) 1.07
The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin (1990) 1.07
Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost (1997) 1.05
Pre-surgical planning and MR-tractography utility in brain tumour resection. Eur Radiol (2009) 1.05
Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol (2000) 1.03
RGD-containing peptides inhibit fibrinogen binding to platelet alpha(IIb)beta3 by inducing an allosteric change in the amino-terminal portion of alpha(IIb). J Biol Chem (2001) 1.03
Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica (2001) 1.03
Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost (2000) 1.02
The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol (1998) 1.02
Significance of epidermal growth factor receptor expression in primary human endometrial cancer. Int J Cancer (1994) 1.02
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study. Arterioscler Thromb Vasc Biol (2007) 1.02
Identification of 217 unreported mutations in the F8 gene in a group of 1,410 unselected Italian patients with hemophilia A. J Hum Genet (2008) 1.01
Inherited thrombophilia and in vitro fertilization implantation failure. Fertil Steril (2001) 1.01
The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study. J Thromb Haemost (2003) 1.00
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost (2012) 0.99
A new vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with decreased stability of CYP2C9 enzyme. J Thromb Haemost (2006) 0.99
PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. Arterioscler Thromb Vasc Biol (1998) 0.99
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism. J Clin Invest (1993) 0.99
Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors. J Thromb Haemost (2009) 0.98
Oxidative stress and platelet activation in homozygous homocystinuria. Circulation (2001) 0.98
Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest (1985) 0.97
Cost of care of haemophilia with inhibitors. Haemophilia (2009) 0.96
Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature. J Thromb Haemost (2012) 0.96
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients. Leukemia (2010) 0.95
Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res (2001) 0.95
Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res (2011) 0.95
Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost (2001) 0.94
Prostaglandins as inhibitors of human platelet aggregation. Br J Haematol (1979) 0.94
Acute confusional migraine: clinical and electroencephalographic aspects. Cephalalgia (1987) 0.94
Why do we need NIRS in migraine? Neurol Sci (2007) 0.93
An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost (1997) 0.93